Germany Walks Diplomatic Tightrope Strengthening China Ties Amid EU Pressure for Tougher Stance Shifting Hiring Landscape Why Skills Are Outweighing Diplomas for EntryLevel Roles Vestas Wind Systems Shares Slide on Margin Guidance Update Pope Leo Warns AI Needs to Be Disarmed Citing ProfitDriven Risks UK Public Borrowing Surges to Highest Since Pandemic as Fuel Prices Weigh on Retail Sales Kevin Warsh Poised to Enter Fed Amid Internal Debate Over Interest Rate Cuts WABC Q1 2026 Earnings EPS Beats Estimates by 306 Stock Gains 119 GLMD Q4 2025 Earnings WiderThanExpected Loss as Galmed Continues Clinical Development RxSight Inc Q1 2026 Earnings EPS Misses Estimates Amid Operational Headwinds INAB Q1 2026 Earnings Narrowed Losses Exceed Expectations as Clinical Progress Continues FNWD Q1 2026 Earnings EPS Miss Slightly as Stock Nudges Higher CLPT Q1 2026 Earnings EPS Misses Estimates by 1478 as Stock Declines AleAnna Inc ANNA Slips Nearly 5 as Stock Tests Key Support Zone GrowGeneration Corp GRWG Faces Modest Decline Near Key Support Level TPG Mortgage Investment Trust MITT Consolidates Near 763 as Support and Resistance Levels Hold Titan Acquisition Corp TACH Holds Steady at 1037 as RangeBound Trading Continues CF Financial CFFI Rallies Above Key Moving Averages Testing Resistance Zone April Jobs Report Expected to Show Modest 55000 Payroll Gain Amid Cooling Labor Market MainStreet Bancshares Inc MNSB Q1 2026 Earnings Strong EPS Surprise of 242 Drives Investor Attention Enterprise Products Partners EPD Slips 3 as Energy Sector Faces Headwinds XCUR Q2 2022 Earnings EPS Misses Estimates as ClinicalStage Biotech Reports No Revenue LKFN Q1 2026 Earnings Slight EPS Beat Amid Modest Stock Decline WDS Q4 2025 Earnings EPS Beats Estimates by 338 as Strong Operational Performance Outweighs Weak Revenue Environment SEER Q1 2026 Earnings Slight EPS Beat Amidst Quiet Revenue Disclosure BMRC Q1 2026 Earnings EPS Misses Estimates as Loan Portfolio Pressures Emerge JBIO Q1 2026 Earnings WiderthanExpected Loss Amid PreRevenue Stage MoonLake Immunotherapeutics MLTX Q1 2026 Earnings EPS Misses Estimates as ClinicalStage Biotech Advances Pipeline